Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 31

1.

Establishing population-based surveillance of diagnostic timeliness using linked cancer registry and administrative data for patients with colorectal and lung cancer.

Pearson C, Fraser J, Peake M, Valori R, Poirier V, Coupland VH, Hiom S, McPhail S, Moffat J, Lyratzopoulos G, Shelton J.

Cancer Epidemiol. 2019 Aug;61:111-118. doi: 10.1016/j.canep.2019.05.010. Epub 2019 Jun 15.

2.

Data Resource Profile: National Cancer Registration Dataset in England.

Henson KE, Elliss-Brookes L, Coupland VH, Payne E, Vernon S, Rous B, Rashbass J.

Int J Epidemiol. 2020 Feb 1;49(1):16-16h. doi: 10.1093/ije/dyz076. No abstract available.

PMID:
31120104
3.

Cohort profile: prescriptions dispensed in the community linked to the national cancer registry in England.

Henson KE, Brock R, Shand B, Coupland VH, Elliss-Brookes L, Lyratzopoulos G, Godfrey P, Haigh A, Hunter K, McCabe MG, Mitchell G, Monckton N, Robson R, Round T, Wong K, Rashbass J.

BMJ Open. 2018 Jul 10;8(7):e020980. doi: 10.1136/bmjopen-2017-020980.

4.

Lung cancer stage-shift following a symptom awareness campaign.

Kennedy MPT, Cheyne L, Darby M, Plant P, Milton R, Robson JM, Gill A, Malhotra P, Ashford-Turner V, Rodger K, Paramasivam E, Johnstone A, Bhartia B, Karthik S, Foster C, Lovatt V, Hewitt F, Cresswell L, Coupland VH, Lüchtenborg M, Jack RH, Moller H, Callister MEJ.

Thorax. 2018 Dec;73(12):1128-1136. doi: 10.1136/thoraxjnl-2018-211842. Epub 2018 Jun 27.

PMID:
29950525
5.

Geographical variations in the use of cancer treatments are associated with survival of lung cancer patients.

Møller H, Coupland VH, Tataru D, Peake MD, Mellemgaard A, Round T, Baldwin DR, Callister MEJ, Jakobsen E, Vedsted P, Sullivan R, Spicer J.

Thorax. 2018 Jun;73(6):530-537. doi: 10.1136/thoraxjnl-2017-210710. Epub 2018 Mar 6.

6.

Investigation of the international comparability of population-based routine hospital data set derived comorbidity scores for patients with lung cancer.

Lüchtenborg M, Morris EJA, Tataru D, Coupland VH, Smith A, Milne RL, Te Marvelde L, Baker D, Young J, Turner D, Nishri D, Earle C, Shack L, Gavin A, Fitzpatrick D, Donnelly C, Lin Y, Møller B, Brewster DH, Deas A, Huws DW, White C, Warlow J, Rashbass J, Peake MD.

Thorax. 2018 Apr;73(4):339-349. doi: 10.1136/thoraxjnl-2017-210362. Epub 2017 Oct 27.

7.

Short-term breast cancer survival in relation to ethnicity, stage, grade and receptor status: national cohort study in England.

Møller H, Henson K, Lüchtenborg M, Broggio J, Charman J, Coupland VH, Davies E, Jack RH, Sullivan R, Vedsted P, Horgan K, Pearce N, Purushotham A.

Br J Cancer. 2016 Nov 22;115(11):1408-1415. doi: 10.1038/bjc.2016.335. Epub 2016 Oct 25.

8.
9.

Resection rate, hospital procedure volume and survival in pancreatic cancer patients in England: Population-based study, 2005-2009.

Coupland VH, Konfortion J, Jack RH, Allum W, Kocher HM, Riaz SP, Lüchtenborg M, Møller H.

Eur J Surg Oncol. 2016 Feb;42(2):190-6. doi: 10.1016/j.ejso.2015.11.003. Epub 2015 Nov 17.

PMID:
26705143
10.

Time and deprivation trends in incidence of primary liver cancer subtypes in England.

Konfortion J, Coupland VH, Kocher HM, Allum W, Grocock MJ, Jack RH.

J Eval Clin Pract. 2014 Aug;20(4):498-504. doi: 10.1111/jep.12188. Epub 2014 Jun 5.

PMID:
24902884
11.

High procedure volume is strongly associated with improved survival after lung cancer surgery.

Lüchtenborg M, Riaz SP, Coupland VH, Lim E, Jakobsen E, Krasnik M, Page R, Lind MJ, Peake MD, Møller H.

J Clin Oncol. 2013 Sep 1;31(25):3141-6. doi: 10.1200/JCO.2013.49.0219. Epub 2013 Jul 29.

PMID:
23897962
12.

Predictive value of dysplasia grading and DNA ploidy in malignant transformation of oral potentially malignant disorders.

Sperandio M, Brown AL, Lock C, Morgan PR, Coupland VH, Madden PB, Warnakulasuriya S, Møller H, Odell EW.

Cancer Prev Res (Phila). 2013 Aug;6(8):822-31. doi: 10.1158/1940-6207.CAPR-13-0001. Epub 2013 Jun 12.

13.

Socioeconomic and ethnic inequalities in screen-detected breast cancer in London.

Davies EA, Renshaw C, Dixon S, Møller H, Coupland VH.

J Public Health (Oxf). 2013 Dec;35(4):607-15. doi: 10.1093/pubmed/fdt002. Epub 2013 Feb 24.

PMID:
23440707
14.

Primary liver cancer incidence and survival in ethnic groups in England, 2001-2007.

Jack RH, Konfortion J, Coupland VH, Kocher HM, Berry DP, Allum W, Linklater KM, Møller H.

Cancer Epidemiol. 2013 Feb;37(1):34-8. doi: 10.1016/j.canep.2012.10.008. Epub 2012 Nov 21.

PMID:
23182222
15.

Differences in outcomes of oesophageal and gastric cancer surgery across Europe.

Dikken JL, van Sandick JW, Allum WH, Johansson J, Jensen LS, Putter H, Coupland VH, Wouters MW, Lemmens VE, van de Velde CJ, van der Geest LG, Larsson HJ, Cats A, Verheij M.

Br J Surg. 2013 Jan;100(1):83-94. doi: 10.1002/bjs.8966. Epub 2012 Nov 23.

16.

Hospital volume, proportion resected and mortality from oesophageal and gastric cancer: a population-based study in England, 2004-2008.

Coupland VH, Lagergren J, Lüchtenborg M, Jack RH, Allum W, Holmberg L, Hanna GB, Pearce N, Møller H.

Gut. 2013 Jul;62(7):961-6. doi: 10.1136/gutjnl-2012-303008. Epub 2012 Oct 19.

PMID:
23086798
17.

Ethnicity in relation to incidence of oesophageal and gastric cancer in England.

Coupland VH, Lagergren J, Konfortion J, Allum W, Mendall MA, Hardwick RH, Linklater KM, Møller H, Jack RH.

Br J Cancer. 2012 Nov 20;107(11):1908-14. doi: 10.1038/bjc.2012.465. Epub 2012 Oct 11.

18.

Differences in breast cancer hormone receptor status in ethnic groups: a London population.

Jack RH, Davies EA, Renshaw C, Tutt A, Grocock MJ, Coupland VH, Møller H.

Eur J Cancer. 2013 Feb;49(3):696-702. doi: 10.1016/j.ejca.2012.09.012. Epub 2012 Oct 8.

PMID:
23058788
19.

Incidence and survival for hepatic, pancreatic and biliary cancers in England between 1998 and 2007.

Coupland VH, Kocher HM, Berry DP, Allum W, Linklater KM, Konfortion J, Møller H, Davies EA.

Cancer Epidemiol. 2012 Aug;36(4):e207-14. doi: 10.1016/j.canep.2012.03.010. Epub 2012 Apr 23.

PMID:
22534487
20.

Mesothelioma incidence projections in South East England.

Riaz SP, Coupland VH, Lüchtenborg M, Peake MD, Møller H.

Eur Respir J. 2012 Oct;40(4):965-8. Epub 2012 Jan 26.

21.

Incidence and survival of oesophageal and gastric cancer in England between 1998 and 2007, a population-based study.

Coupland VH, Allum W, Blazeby JM, Mendall MA, Hardwick RH, Linklater KM, Møller H, Davies EA.

BMC Cancer. 2012 Jan 12;12:11. doi: 10.1186/1471-2407-12-11.

22.

Trends in incidence of small cell lung cancer and all lung cancer.

Riaz SP, Lüchtenborg M, Coupland VH, Spicer J, Peake MD, Møller H.

Lung Cancer. 2012 Mar;75(3):280-4. doi: 10.1016/j.lungcan.2011.08.004. Epub 2011 Sep 3.

PMID:
21893364
23.

Variation in surgical resection for lung cancer in relation to survival: population-based study in England 2004-2006.

Riaz SP, Lüchtenborg M, Jack RH, Coupland VH, Linklater KM, Peake MD, Møller H.

Eur J Cancer. 2012 Jan;48(1):54-60. doi: 10.1016/j.ejca.2011.07.012. Epub 2011 Aug 24.

PMID:
21871792
24.

Hospital volume and survival in oesophagectomy and gastrectomy for cancer.

Anderson O, Ni Z, Møller H, Coupland VH, Davies EA, Allum WH, Hanna GB.

Eur J Cancer. 2011 Nov;47(16):2408-14. doi: 10.1016/j.ejca.2011.07.001. Epub 2011 Aug 9.

PMID:
21835609
25.

Factors predicting malignant transformation in oral potentially malignant disorders among patients accrued over a 10-year period in South East England.

Warnakulasuriya S, Kovacevic T, Madden P, Coupland VH, Sperandio M, Odell E, Møller H.

J Oral Pathol Med. 2011 Oct;40(9):677-83. doi: 10.1111/j.1600-0714.2011.01054.x. Epub 2011 Jul 18.

PMID:
21762430
26.

Using maps and funnel plots to explore variation in place of death from cancer within London, 2002-2007.

Madden P, Coupland V, Møller H, Davies E.

Palliat Med. 2011 Jun;25(4):323-32. doi: 10.1177/0269216311398700. Epub 2011 Mar 11.

PMID:
21398346
27.

Does place of death from cancer vary between ethnic groups in South East England?

Coupland VH, Madden P, Jack RH, Møller H, Davies EA.

Palliat Med. 2011 Jun;25(4):314-22. doi: 10.1177/0269216310395986. Epub 2011 Jan 19.

PMID:
21248180
28.

Investigation of low 5-year relative survival for breast cancer in a London cancer network.

Davies EA, Linklater KM, Coupland VH, Renshaw C, Toy J, Park R, Petit J, Housden C, Møller H.

Br J Cancer. 2010 Sep 28;103(7):1076-80. doi: 10.1038/sj.bjc.6605857. Epub 2010 Aug 24.

29.

Is it possible to determine use of hospice palliative care services by matching hospice and cancer registry data?

Coupland VH, Lee W, Madden P, Sykes N, Heal R, Møller H, Davies EA.

Palliat Med. 2010 Dec;24(8):807-11. doi: 10.1177/0269216310377815. Epub 2010 Aug 13.

PMID:
20709712
30.

The future burden of cancer in London compared with England.

Coupland VH, Okello C, Davies EA, Bray F, Møller H.

J Public Health (Oxf). 2010 Mar;32(1):83-9. doi: 10.1093/pubmed/fdp082. Epub 2009 Aug 13.

PMID:
19679689
31.

Trends in the epidemiology of larynx and lung cancer in south-east England, 1985-2004.

Coupland VH, Chapman P, Linklater KM, Sehgal A, Møller H, Davies EA.

Br J Cancer. 2009 Jan 13;100(1):167-9. doi: 10.1038/sj.bjc.6604787. Epub 2008 Nov 18.

Supplemental Content

Loading ...
Support Center